S2C6:Clinical Trial Statistics

原文始发于微信公众号(化学音乐文化):S2C6:Clinical Trial Statistics

S2C6:Clinical Trial Statistics

JanFourman,PhD, EdD,MBA, MSRA

S2C6:Clinical Trial Statistics

Eli Lilly – Pharma registration for diabetes/endocrine, women/men’s health, neural science, oncology, bone/muscle/joint therapeutic areas – 5 years
Eli Lilly – Pharmacovigilance – 7 years
Eli Lilly – Regulatory Intelligence – 3 Years
Purdue University and Roche Diagnostics – Teaching global pharma development, Africa and US
Consultant for Indiana Technical Assistance Program
Invited conference speaker
Published author

S2C6:Clinical Trial Statistics
S2C6:Clinical Trial Statistics

扫描左侧二维码,获取视频课;扫描右侧二维码,获取音频课

Clinical Trial Statistics

Utilizing Statistical Concepts to Make Key Decisions when Designing Clinical Trials:

Introduce clinical trial statistics and their relevance to designing trials

Understand terminology

identify information to compute a sample size

understand how statistical tests are selected

Emphasize the importance of an ongoing collaboration between the statistician and the physician

发布者:药时代,转载请首先联系contact@drugtimes.cn获得授权

(0)
打赏 为好文打赏 支持药时代 共创新未来! 为好文打赏 支持药时代 共创新未来!
上一篇 2020年2月18日 12:21
下一篇 2020年2月18日 12:29

相关推荐

分享本页
返回顶部
「药时代创新药BD高阶研讨会」将于2023年3月11-12日在上海举办,点击这里了解详情并报名~